drugset / Trial / NCT05855863

Clinical Study of GKT in Diabetes Related Dementia

NCT05855863 ↗

Phase 4 Unknown 370 enrolled Shanghai 10th People's Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Recently a new clinical dementia subgroup based on brain imaging, called "diabetes related dementia (DrD)". DrD, unlike Alzheimer's disease and vascular dementia, is considered a "controllable" or "modifiable" form of dementia. However, there is currently a lack of corresponding treatment measures. Ginkgo biloba ketone ester tablets are extracts of Ginkgo biloba leaves. Previous studies have shown that they can increase cerebral blood flow, reduce cerebrovascular resistance, improve cerebral circulation, and are beneficial for the treatment of cognitive impairment. This project intends to explore the role of ginkgo ketoester tablets in diabetes related dementia through a multicenter randomized double-blind controlled clinical study.

Timeline

Start
2023-12-01
Primary completion
2026-06-30
Completion
2026-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ginkgo Ketone Ester Tablets Unknown 0.5 g Oral

Indications